Keloid Treatment Market: By Type (Compression Therapy, Intralesional Corticosteroid Injections, Occlusive Dressing, Excision, Cryosurgery, Laser Therapy, Radiation Therapy, Interferon Therapy), By End User (Hospitals, Beauty Centres, Dermatology Clinics, Others) and Geography  

Keloid Treatment Market was valued at USD 3620 million in 2022 and is poised to grow at a CAGR of 5.8% from 2023-2029. A keloid is an overgrown scar that rises beyond the skin's surface as a result of the creation of extra scar tissue on the healed skin area following surgery, a burn, or an injury. Keloids are most commonly found on the hands, legs, and neck, but they can appear anywhere. Although the exact cause of keloids is unknown, numerous factors such as age, gender, blood group, type of lesion, anatomical site, number of sites wounded, and family history can all play a role in identifying the cause. Other factors that may contribute to keloid formation and in predicting keloid behaviour during diagnosis or therapy include delayed wound healing and hypertension. Excess of a protein in ones skin during cure process after an injury causes raised scar, which is known as keloid. Keloid treatment greatly helps to flatten, soften and north america stretch and shrink film the keloid as they are tough to get rid of entirely. Healthcare experts generally give combination treatment for obtaining high treatment efficiency rates. Keloid scar can reduce over a period. Keloid scars are generally found in people of age group 10-30 years Keloid scar cases are hugely seen in Asian, African as well as American People. Acquisitions, mergers, collaborations and new product introduction are some of the effective strategies followed by the industries of the market in order to strengthen their place in the market. For Instance, Lumenis acquired An Israel aesthetic company named Pollogen Ltd for expanding its product portfolio in the year 2015. Key players of this market are also bringing new technologies in the market. An abnormal proliferation of a scar tissue which farms at site of cutaneous injury is called as keloid. Keloid scar doesnt regress and progress beyond the scars original margin and it can reduce over a period of time. Keloids are the benign fibroproliferative dermal tumours.